<p>Ranger Investment Management L.P. 在最近向证券交易委员会（SEC）提交的文件中表示，在第二季度减少了对 Mesa Laboratories, Inc.（NASDAQ:MLAB - 免费报告）7.2% 的持股。该公司在本季度出售了 16,698 股后，持有 214,290 股这家医疗仪器供应商的股票。Ranger Investment Management L.P. 在最近一个季度末持有的 Mesa Laboratories 的股份占比为 3.89%，价值为 20,190,000 美元。</p>
<p>获取 <strong>Mesa Laboratories</strong> 的提醒：</p>
<p>其他一些机构投资者最近也增加或减少了对 MLAB 的持股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度将其在 Mesa Laboratories 的持股增加了 4.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前持有 3,068 股这家医疗仪器供应商的股票，价值为 364,000 美元，此前在该期间购买了 143 股。Franklin Resources Inc. 在第二季度将其在 Mesa Laboratories 的持股增加了 5.5%。Franklin Resources Inc. 目前持有 3,476 股这家医疗仪器供应商的股票，价值为 328,000 美元，此前在上个季度购买了 182 股。American Century Companies Inc. 在第二季度将其在 Mesa Laboratories 的持股增加了 1.5%。American Century Companies Inc. 目前持有 13,431 股这家医疗仪器供应商的股票，价值为 1,265,000 美元，此前在该期间购买了 194 股。阿拉斯加州财政部在第二季度将其在 Mesa Laboratories 的持股增加了 7.1%。阿拉斯加州财政部目前持有 3,224 股这家医疗仪器供应商的股票，价值为 303,000 美元，此前在上个季度购买了 213 股。最后，加拿大皇家银行在第一季度将其在 Mesa Laboratories 的持股增加了 1.2%。加拿大皇家银行目前持有 30,772 股这家医疗仪器供应商的股票，价值为 3,652,000 美元，此前在该期间购买了 353 股。机构投资者和对冲基金持有该公司 90.60% 的股份。</p>
<h2>Mesa Laboratories 股价下跌 1.1%</h2>
<p>Mesa Laboratories 的股票在周五开盘价为 77.77 美元。该公司的市值为 4.2929 亿美元，市盈率为-243.03，贝塔系数为 0.90。Mesa Laboratories, Inc. 的一年最低价为 55.45 美元，一年最高价为 155.12 美元。该公司的 50 日移动平均价格为 75.50 美元，200 日移动平均价格为 77.92 美元。该公司的债务与股本比率为 0.95，速动比率为 1.44，流动比率为 2.02。</p>
<h2>Mesa Laboratories 分红公告</h2>
<p>该公司最近宣布了季度分红，将于 12 月 15 日（星期一）支付。11 月 28 日（星期五）登记的投资者将获得 0.16 美元的分红。除息日为 11 月 28 日（星期五）。这代表着年化分红为 0.64 美元，分红收益率为 0.8%。Mesa Laboratories 的分红支付比率（DPR）为-200.00%。</p>
<h2>华尔街分析师预测增长</h2>
<p>一些研究分析师最近对 MLAB 股票发表了评论。华尔街 Zen 在 11 月 8 日（星期六）的研究报告中将 Mesa Laboratories 的股票评级从 “持有” 上调至 “买入”。Weiss Ratings 在 10 月 8 日（星期三）的研究报告中重申了对 Mesa Laboratories 股票的 “卖出（d）” 评级。最后，Zacks Research 在周四将 Mesa Laboratories 的评级上调至 “强烈卖出”。一位投资分析师对该股票给予了 “持有” 评级，两位分析师对该股票给予了 “卖出” 评级。根据 MarketBeat.com 的数据，Mesa Laboratories 目前的平均评级为 “卖出”，共识目标价为 67.00 美元。</p>
<p><strong>获取我们对 Mesa Laboratories 的最新股票分析</strong></p>
<h2>Mesa Laboratories 公司简介</h2>
<p>（免费报告）</p>
<p>Mesa Laboratories, Inc. 在北美、欧洲、亚太地区及国际上开发、设计、制造、销售和服务生命科学工具及质量控制产品和服务。灭菌和消毒控制部门提供生物、化学和清洁指示剂，用于评估制药、医疗器械和医疗行业中灭菌、去污、消毒和清洁过程的有效性。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 Mesa Laboratories</li>
<li>动量投资与长期投资的区别</li>
<li>迪士尼的 10 亿美元交易将其魔力带入 OpenAI</li>
<li>拥有债券的风险</li>
<li>为什么亚马逊可能在几周内成为 300 美元的股票</li>
<li>即将到来的 IPO 股票锁定期，解释</li>
<li>Adobe 在财报后获得提振：长期前景看好</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUxBQg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUxBQg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 Mesa Laboratories 吗？</h2>
<p>在你考虑投资 Mesa Laboratories 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前立即购买……而 Mesa Laboratories 并不在名单上。</p>
<p>虽然 Mesa Laboratories 目前在分析师中被评为 “卖出”，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

MLAB

<p>Ranger Investment Management L.P. 在第二季度减少了对 Mesa Laboratories, Inc. 的持股，降幅为 7.2%，目前持有该公司 3.89% 的股份。Mesa Laboratories 的股票开盘价为 77.77 美元，市值为 4.2929 亿美元。分析师的评级意见不一，普遍目标价为 67.00 美元。该公司宣布季度股息为 0.16 美元，将于 12 月 15 日支付</p>

<p>Ranger Investment Management L.P. reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 7.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 214,290 shares of the medical instruments supplier's stock after selling 16,698 shares during the quarter. Ranger Investment Management L.P. owned 3.89% of Mesa Laboratories worth $20,190,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Ranger Investment Management L.P. 在最近向证券交易委员会（SEC）提交的文件中表示，在第二季度减少了对 Mesa Laboratories, Inc.（NASDAQ:MLAB - 免费报告）7.2% 的持股。该公司在本季度出售了 16,698 股后，持有 214,290 股这家医疗仪器供应商的股票。Ranger Investment Management L.P. 在最近一个季度末持有的 Mesa Laboratories 的股份占比为 3.89%，价值为 20,190,000 美元。</p>
</div><p>Get <strong>Mesa Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Mesa Laboratories</strong> 的提醒：</p>
</div><p>A number of other institutional investors also recently added to or reduced their stakes in MLAB. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Mesa Laboratories by 4.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,068 shares of the medical instruments supplier's stock valued at $364,000 after purchasing an additional 143 shares during the period. Franklin Resources Inc. grew its position in Mesa Laboratories by 5.5% in the 2nd quarter. Franklin Resources Inc. now owns 3,476 shares of the medical instruments supplier's stock valued at $328,000 after buying an additional 182 shares in the last quarter. American Century Companies Inc. increased its stake in Mesa Laboratories by 1.5% during the 2nd quarter. American Century Companies Inc. now owns 13,431 shares of the medical instruments supplier's stock valued at $1,265,000 after buying an additional 194 shares during the period. State of Alaska Department of Revenue raised its position in shares of Mesa Laboratories by 7.1% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,224 shares of the medical instruments supplier's stock worth $303,000 after buying an additional 213 shares in the last quarter. Finally, Royal Bank of Canada lifted its stake in shares of Mesa Laboratories by 1.2% in the 1st quarter. Royal Bank of Canada now owns 30,772 shares of the medical instruments supplier's stock worth $3,652,000 after acquiring an additional 353 shares during the period. Institutional investors and hedge funds own 90.60% of the company's stock.</p>
<div class="lb-trans"><p>其他一些机构投资者最近也增加或减少了对 MLAB 的持股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度将其在 Mesa Laboratories 的持股增加了 4.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前持有 3,068 股这家医疗仪器供应商的股票，价值为 364,000 美元，此前在该期间购买了 143 股。Franklin Resources Inc. 在第二季度将其在 Mesa Laboratories 的持股增加了 5.5%。Franklin Resources Inc. 目前持有 3,476 股这家医疗仪器供应商的股票，价值为 328,000 美元，此前在上个季度购买了 182 股。American Century Companies Inc. 在第二季度将其在 Mesa Laboratories 的持股增加了 1.5%。American Century Companies Inc. 目前持有 13,431 股这家医疗仪器供应商的股票，价值为 1,265,000 美元，此前在该期间购买了 194 股。阿拉斯加州财政部在第二季度将其在 Mesa Laboratories 的持股增加了 7.1%。阿拉斯加州财政部目前持有 3,224 股这家医疗仪器供应商的股票，价值为 303,000 美元，此前在上个季度购买了 213 股。最后，加拿大皇家银行在第一季度将其在 Mesa Laboratories 的持股增加了 1.2%。加拿大皇家银行目前持有 30,772 股这家医疗仪器供应商的股票，价值为 3,652,000 美元，此前在该期间购买了 353 股。机构投资者和对冲基金持有该公司 90.60% 的股份。</p>
</div><h2>Mesa Laboratories Trading Down 1.1%</h2>
<div class="lb-trans"><h2>Mesa Laboratories 股价下跌 1.1%</h2>
</div><p>Mesa Laboratories stock opened at $77.77 on Friday. The firm has a market cap of $429.29 million, a price-to-earnings ratio of -243.03 and a beta of 0.90. Mesa Laboratories, Inc. has a 1 year low of $55.45 and a 1 year high of $155.12. The firm's 50 day moving average price is $75.50 and its two-hundred day moving average price is $77.92. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.44 and a current ratio of 2.02.</p>
<div class="lb-trans"><p>Mesa Laboratories 的股票在周五开盘价为 77.77 美元。该公司的市值为 4.2929 亿美元，市盈率为-243.03，贝塔系数为 0.90。Mesa Laboratories, Inc. 的一年最低价为 55.45 美元，一年最高价为 155.12 美元。该公司的 50 日移动平均价格为 75.50 美元，200 日移动平均价格为 77.92 美元。该公司的债务与股本比率为 0.95，速动比率为 1.44，流动比率为 2.02。</p>
</div><h2>Mesa Laboratories Dividend Announcement</h2>
<div class="lb-trans"><h2>Mesa Laboratories 分红公告</h2>
</div><p>The business also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 28th will be given a $0.16 dividend. The ex-dividend date is Friday, November 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.8%. Mesa Laboratories's dividend payout ratio (DPR) is -200.00%.</p>
<div class="lb-trans"><p>该公司最近宣布了季度分红，将于 12 月 15 日（星期一）支付。11 月 28 日（星期五）登记的投资者将获得 0.16 美元的分红。除息日为 11 月 28 日（星期五）。这代表着年化分红为 0.64 美元，分红收益率为 0.8%。Mesa Laboratories 的分红支付比率（DPR）为-200.00%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of research analysts recently commented on MLAB shares. Wall Street Zen upgraded shares of Mesa Laboratories from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, November 8th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Mesa Laboratories in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded Mesa Laboratories to a &#34;strong sell&#34; rating in a report on Thursday. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Mesa Laboratories currently has an average rating of &#34;Sell&#34; and a consensus target price of $67.00.</p>
<div class="lb-trans"><p>一些研究分析师最近对 MLAB 股票发表了评论。华尔街 Zen 在 11 月 8 日（星期六）的研究报告中将 Mesa Laboratories 的股票评级从 “持有” 上调至 “买入”。Weiss Ratings 在 10 月 8 日（星期三）的研究报告中重申了对 Mesa Laboratories 股票的 “卖出（d）” 评级。最后，Zacks Research 在周四将 Mesa Laboratories 的评级上调至 “强烈卖出”。一位投资分析师对该股票给予了 “持有” 评级，两位分析师对该股票给予了 “卖出” 评级。根据 MarketBeat.com 的数据，Mesa Laboratories 目前的平均评级为 “卖出”，共识目标价为 67.00 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Mesa Laboratories</strong></p>
<div class="lb-trans"><p><strong>获取我们对 Mesa Laboratories 的最新股票分析</strong></p>
</div><h2>Mesa Laboratories Profile</h2>
<div class="lb-trans"><h2>Mesa Laboratories 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.</p>
<div class="lb-trans"><p>Mesa Laboratories, Inc. 在北美、欧洲、亚太地区及国际上开发、设计、制造、销售和服务生命科学工具及质量控制产品和服务。灭菌和消毒控制部门提供生物、化学和清洁指示剂，用于评估制药、医疗器械和医疗行业中灭菌、去污、消毒和清洁过程的有效性。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Mesa Laboratories</li>
<li>Differences Between Momentum Investing and Long Term Investing</li>
<li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li>
<li>The Risks of Owning Bonds</li>
<li>Why Amazon Could Be a $300 Stock Within Weeks</li>
<li>Upcoming IPO Stock Lockup Period, Explained</li>
<li>Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Mesa Laboratories</li>
<li>动量投资与长期投资的区别</li>
<li>迪士尼的 10 亿美元交易将其魔力带入 OpenAI</li>
<li>拥有债券的风险</li>
<li>为什么亚马逊可能在几周内成为 300 美元的股票</li>
<li>即将到来的 IPO 股票锁定期，解释</li>
<li>Adobe 在财报后获得提振：长期前景看好</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUxBQg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=MLAB"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Mesa Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Mesa Laboratories 吗？</h2>
</div><p>Before you consider Mesa Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑投资 Mesa Laboratories 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前立即购买……而 Mesa Laboratories 并不在名单上。</p>
</div><p>While Mesa Laboratories currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Mesa Laboratories 目前在分析师中被评为 “卖出”，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Ranger Investment Management L.P. 出售了 Mesa Laboratories, Inc. 的 $MLAB 股票